Key result
The optimal strategy for managing coronary artery disease in patients undergoing transcatheter aortic valve replacement remains debated.
Why the study?
The optimal strategy for managing coexisting coronary artery disease in patients undergoing transcatheter aortic valve replacement remains debated.
The optimal strategy for managing coronary artery disease in patients undergoing TAVR remains debated.
Leaves CAD management in TAVR unresolved; dedicated RCTs needed before practice guidance.
Aortic stenosis (AS) is a progressive condition characterized by the narrowing of the aortic valve and often coexists with coronary artery disease (CAD) due to overlapping risk factors such as aging, hypertension, and hyperlipidemia. In patients undergoing transcatheter aortic valve replacement (TAVR), addressing obstructive coronary lesions is crucial for preventing adverse cardiac events, including myocardial infarction and heart failure. However, the optimal strategy for managing CAD in patients undergoing TAVR remains debated, with various strategies being employed to address this coexistence.
No takes yet. Share an insight, caveat, or question.
Rajendran et al. (2025) conducted a review in Aortic stenosis and coronary artery disease. Management strategies for coronary artery disease was evaluated. The optimal strategy for managing coronary artery disease in patients undergoing transcatheter aortic valve replacement remains debated.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: